Fidelity International’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-126,521
Closed -$2.1M 1042
2019
Q3
$2.1M Sell
126,521
-7,342
-5% -$102K ﹤0.01% 598
2019
Q2
$1.84M Sell
133,863
-190,328
-59% -$2.91M ﹤0.01% 606
2019
Q1
$5.59M Buy
+324,191
New +$5.13M 0.01% 503

Other funds holding OXFD

Fidelity International's OXFD Position: Q4 2019 in Review

Fidelity International sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q4 2019, closing a stake of 126,521 shares — an estimated $2.1M sold.

Fidelity International first reported a position in OXFD in Q1 2019 and held it in 3 quarters. The position peaked at $5.59M in Q1 2019. 68 funds tracked by Wall St. Rank hold OXFD as of Q4 2019.

  • Fidelity International reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q4 2019 after selling out during the quarter.
  • Fidelity International sold 126,521 Oxford Immunotec Global PLC Ordinary Shares shares in Q4 2019, an estimated $2.1M.
  • Fidelity International first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q1 2019 and held it in 3 quarters.
  • Fidelity International's Oxford Immunotec Global PLC Ordinary Shares position peaked at $5.59M in Q1 2019.
  • 68 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q4 2019.

Based on Fidelity International's 13F filing for Q4 2019, filed 7 Feb 2020.